GPT Healthcare Limited has informed the Exchange about Transcript
GPTHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GPT Healthcare reported Q1 FY26 revenue of INR 107 crores, up 9.5% year-on-year, with EBITDA of INR 18.9 crores at a 17.9% margin. Margins were dragged down by initial losses of around INR 4.5 crores from the newly commissioned 158-bed Raipur hospital; ex-Raipur, steady-state EBITDA margin would be over 22%. Profit after tax stood at INR 7.7 crores. The company now operates 719 beds across five multi-specialty hospitals, with a new 150-bed Jamshedpur facility (INR 60 crore investment) expected by end of calendar 2026, keeping the 1,000-bed target within reach in 2-2.5 years. Management guided for 15% full-year revenue growth and 22.5-23% EBITDA margins for the four mature assets, while expecting Raipur to hit EBITDA breakeven within 12-15 months. Network occupancy was 42% (impacted by the new Raipur addition) and ARPOB rose to INR 38,913, with management targeting 4-4.5% ARPOB growth annually.
The Raipur hospital is a near-term margin drag but the management's asset-light expansion model and clear bed-capacity roadmap provide visibility on growth. Investors should track the Raipur occupancy ramp-up, full-year delivery of the 15% revenue growth target, and average occupancy guidance (which management deferred to the next quarter).